chest pain - Nursing Case Study
Pathophysiology
• Primary mechanism: Myocardial ischemia results from reduced blood flow to the heart muscle due to coronary artery disease, leading to an oxygen supply-demand mismatch and subsequent chest pain or angina.
• Secondary mechanism: Inflammation of the pleura, known as pleuritis, can cause sharp chest pain due to friction between the inflamed pleural layers during respiration, exacerbating pain with deep breaths or coughing.
• Key complication: If untreated, these mechanisms can lead to myocardial infarction or respiratory compromise, significantly impacting cardiac and pulmonary function and necessitating prompt medical intervention.
Patient Profile
Demographics:
52-year-old male, construction worker
History:
• Key past medical history: Hypertension, hyperlipidemia
• Current medications: Lisinopril 20 mg daily, Atorvastatin 40 mg daily
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Chest pain
• Key symptoms: Intermittent chest pain radiating to the left arm, shortness of breath, nausea, dizziness
• Vital signs: Blood pressure 160/95 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air
Section 1
As the initial assessment continues, the patient's chest pain becomes more severe and is now constant rather than intermittent. His shortness of breath worsens, and he appears diaphoretic and anxious. Physical examination reveals jugular venous distention, an S3 heart sound upon auscultation, and crackles in the lung bases, indicating potential heart failure. The patient's skin is cool and clammy, and his oxygen saturation has decreased further to 88% on room air, necessitating supplemental oxygen. An electrocardiogram (ECG) is performed, showing ST-segment depression in leads V2 to V4, suggesting myocardial ischemia.
In response to these findings, the healthcare team orders a series of laboratory tests, including cardiac enzymes, a complete blood count, and basic metabolic panel. Results show elevated troponin levels, confirming myocardial injury, while the complete blood count reveals a slight leukocytosis, potentially indicating an inflammatory process. The patient's blood glucose is elevated, which could be stress-induced hyperglycemia or undiagnosed diabetes, necessitating further investigation.
These assessment findings and lab results raise concerns about the development of an acute coronary syndrome, with potential complications such as heart failure and arrhythmias. The healthcare team initiates treatment with aspirin, a nitroglycerin drip for pain and to reduce myocardial oxygen demand, and beta-blockers to control heart rate and blood pressure. The patient is closely monitored for any signs of hemodynamic instability or further deterioration, as the risk of progression to myocardial infarction remains high. This situation requires careful clinical reasoning to adjust the treatment plan and anticipate possible complications.
Section 2
As the healthcare team continues to monitor the patient closely, his condition begins to show signs of instability. Despite the administration of nitroglycerin and beta-blockers, the patient's chest pain remains unabated, and his anxiety heightens. His blood pressure begins to fluctuate, dropping to 90/60 mmHg, which raises concern for hemodynamic instability. The heart rate remains elevated at 110 beats per minute, and despite supplemental oxygen, his oxygen saturation struggles to maintain above 90%. These indicators suggest a worsening of cardiac function and raise suspicion of impending cardiogenic shock.
In response to these changes, the team decides to perform a repeat ECG and orders an echocardiogram to assess cardiac function more thoroughly. The repeat ECG now shows T-wave inversions in addition to the previous ST-segment depression, which is consistent with evolving ischemia and places the patient at increased risk for arrhythmias. The echocardiogram reveals a reduced ejection fraction of 35%, confirming significant left ventricular dysfunction. The presence of new-onset heart failure symptoms, combined with a rising troponin level, suggests an evolving myocardial infarction that requires immediate intervention.
The healthcare team revises the treatment plan, initiating a continuous infusion of a diuretic to reduce fluid overload and alleviate pulmonary congestion. Additionally, they consider the introduction of an inotropic agent to support cardiac output and mitigate the risk of shock. The patient is prepared for transfer to the cardiac catheterization lab for potential percutaneous coronary intervention, as the benefits of revascularization may outweigh the risks given the rapid deterioration. This critical juncture underscores the importance of dynamic clinical reasoning and swift adaptation to the patient's evolving condition, as the team seeks to stabilize his status and prevent further complications.
Section 3
As the patient is transferred to the cardiac catheterization lab, the healthcare team closely monitors his status, paying particular attention to his hemodynamic parameters. Upon arrival, the patient exhibits increased respiratory distress, with audible crackles upon auscultation of the lungs, suggesting worsening pulmonary edema. His blood pressure has become more labile, fluctuating between 85/55 mmHg and 95/60 mmHg, signaling persistent hemodynamic instability. Despite the initiation of the diuretic infusion, fluid overload remains a concern, as evidenced by continued peripheral edema and jugular venous distention. Heart rate continues to hover around 115 beats per minute, and oxygen saturation struggles at 88%, despite high-flow oxygen support.
The catheterization procedure uncovers critical findings: a severe stenosis in the left anterior descending artery, confirming the need for immediate percutaneous coronary intervention (PCI). As the interventional cardiologist performs the balloon angioplasty and stent placement, the patient experiences a transient episode of ventricular tachycardia, underscoring the precarious nature of his cardiac status. Quick defibrillation restores a stable rhythm, but the incident highlights the heightened risk of arrhythmias due to myocardial irritability. Post-procedure, the patient's blood pressure shows slight improvement, stabilizing at 100/65 mmHg, and heart rate decreases to 100 beats per minute, indicating a positive response to the revascularization efforts.
However, the team remains vigilant, recognizing that while the successful PCI has alleviated the acute ischemic burden, the patient is not yet out of danger. The reduced ejection fraction and the episode of ventricular tachycardia are significant indicators of ongoing cardiac compromise. The team decides to continue inotropic support to enhance cardiac output and plans for careful titration of medications to optimize cardiac function while preventing further arrhythmic complications. As they prepare to transfer the patient back to the intensive care unit, the focus shifts to meticulous monitoring and secondary prevention strategies to address the underlying causes and prevent recurrence.
Section 4
As the patient is transferred back to the intensive care unit, the healthcare team conducts a thorough initial assessment to establish a baseline for ongoing monitoring. Upon examination, the patient appears slightly more alert, yet he remains dyspneic with labored breathing. Auscultation reveals persistent crackles in both lung bases, indicating unresolved pulmonary edema. The patient's skin is cool and clammy, with peripheral pulses weak but palpable. Despite high-flow oxygen therapy, oxygen saturation remains at 90%, necessitating consideration for non-invasive ventilation support to improve oxygenation.
Laboratory results return from earlier samples, revealing elevated troponin levels, indicating ongoing myocardial injury. B-type natriuretic peptide (BNP) is markedly increased, further confirming significant cardiac strain and heart failure exacerbation. Electrolyte imbalances are present, with hypokalemia noted, likely secondary to diuretic therapy, highlighting the need for careful electrolyte management to prevent further arrhythmias. Arterial blood gas analysis shows a mild respiratory alkalosis with partial compensation, reflecting the patient's respiratory distress.
In response to these findings, the team prioritizes adjusting the patient's management plan. The diuretic regimen is carefully titrated to aggressively yet safely manage fluid overload, while potassium supplementation is initiated to correct the hypokalemia. Inotropic support is continued to maintain cardiac output, and discussions about the potential need for mechanical circulatory support, such as an intra-aortic balloon pump, are initiated. The plan also includes frequent reassessment of hemodynamic status and respiratory function, anticipating possible need for escalation of respiratory support. The focus remains on stabilizing the patient, addressing the acute heart failure symptoms, and preventing further complications as the patient navigates through this critical phase.
Section 5
As the healthcare team continues to closely monitor the patient, a change in his status becomes evident. Approximately four hours after the adjustments to his management plan were implemented, the patient exhibits signs of increasing respiratory distress. Despite the initiation of non-invasive ventilation, his oxygen saturation drops further to 86%, and his respiratory rate climbs to 32 breaths per minute. The patient is visibly agitated, and his work of breathing is markedly increased. Auscultation reveals worsening crackles throughout both lung fields, suggesting an escalation of pulmonary edema despite aggressive diuretic therapy.
Concurrently, the patient's hemodynamic status shows concerning trends. Blood pressure readings have declined to 85/55 mmHg, prompting concerns about potential cardiogenic shock. Heart rate remains elevated at 110 beats per minute, and there is now evidence of jugular venous distention, further indicating worsening heart failure. The healthcare team convenes urgently to reassess the current treatment strategy, considering the potential need for mechanical ventilation to alleviate respiratory distress and stabilize oxygenation.
In light of these developments, inotropic support is re-evaluated, and vasopressor therapy is considered to address hypotension and support perfusion. Repeat laboratory tests reveal persistently elevated troponin levels, suggesting ongoing myocardial damage, and a further decrease in serum potassium to 3.0 mEq/L, despite ongoing supplementation. The patient is placed on continuous cardiac monitoring to detect any emerging arrhythmias due to electrolyte imbalances. The team remains vigilant, recognizing that these changes may necessitate the escalation to advanced cardiac support interventions, such as the insertion of an intra-aortic balloon pump, to stabilize the patient's deteriorating cardiac function and prevent further complications.